CVS Health

CVS Health Enters Biosimilars Market with Launch of Cordavis Subsidiary
CVS Health Enters Biosimilars Market with Launch of Cordavis Subsidiary
BioSpace
CVS Health
biosimilars
Cordavis
Flag link:
Viome, a microbiome startup, raises $86.5M, inks distribution deal with CVS
Viome, a microbiome startup, raises $86.5M, inks distribution deal with CVS
TechCrunch
Viome
microbiome
CVS Health
Flag link:
Blue Shield of California looks to cut reliance on CVS, taps Amazon
Blue Shield of California looks to cut reliance on CVS, taps Amazon
Yahoo/Reuters
Blue Shield
insurers
California
CVS Health
PBMs
Amazon
Mark Cuban Cost Plus Drugs
Flag link:
CVS Health Profits Drop To $1.9 Billion As Restructuring Costs Take Hold
CVS Health Profits Drop To $1.9 Billion As Restructuring Costs Take Hold
Forbes
CVS Health
earnings
restructuring
Flag link:
CVS Caremark, GoodRx partner to lower drug costs
CVS Caremark, GoodRx partner to lower drug costs
Beckers Hospital Review
CVS Health
CVS Caremark
GoodRx
drug pricing
Flag link:
For 2023, Five For-Profit Retailers and PBMs Dominate an Evolving 340B Contract Pharmacy Market
For 2023, Five For-Profit Retailers and PBMs Dominate an Evolving 340B Contract Pharmacy Market
Drug Channels
340B
drug pricing
CVS Health
Walgreens
Cigna
Express Scripts
Unitedhealth Group
OptumRx
Walmart
PBMs
Flag link:
With CVS Health’s Exit, Walgreens Steps Up Clinical Research With Cancer Test Partner
With CVS Health’s Exit, Walgreens Steps Up Clinical Research With Cancer Test Partner
Forbes
Walgreens
CVS Health
clinical trials
cancer
Freenome
Flag link:
Why Is CVS Health Clinical Trial Services Closing?
Why Is CVS Health Clinical Trial Services Closing?
Xtalks
CVS Health
clinical trials
Flag link:
CVS’ Shuttered Clinical Trials Business Doesn’t Mean Decentralized Models Are Doomed, Exec Says
CVS’ Shuttered Clinical Trials Business Doesn’t Mean Decentralized Models Are Doomed, Exec Says
MedCity News
CVS Health
Carebox
clinical trials
decentralized clinical trials
Flag link:
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Flag link:
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Flag link:
CVS Health Completes $8 Bln Signify Health Acquisition
CVS Health Completes $8 Bln Signify Health Acquisition
NASDAQ
CVS Health
Signify Health
M&A
Flag link:
CVS To Close Signify Health Deal, Launching A National In-Home Care Business
CVS To Close Signify Health Deal, Launching A National In-Home Care Business
Forbes
CVS Health
M&A
Signify Health
home healthcare
Flag link:
CVS close to $10.5B deal for Oak Street Health: WSJ
CVS close to $10.5B deal for Oak Street Health: WSJ
Medical Marketing and Media
CVS Health
Oak Street Health
M&A
Flag link:
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
Drug Channels
PBMs
Caremark
CVS Health
Express Scripts
Cigna
OptumRx
United Health
formularies
insulin
biosimilars
Humira
Flag link:
CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims
CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims
Reuters
legal
opioids
opioid crisis
Walgreens
CVS Health
Walmart
Flag link:
CVS Is in Another Bidding War
CVS Is in Another Bidding War
Motley Fool
CVS Health
Cano Health
M&A
Flag link:
CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback
CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback
Fierce Pharma
CVS Health
Bristol Myers Squibb
Pfizer
Eliquis
formularies
bloodthinners
Flag link:
CVS Health Banks on Trust to Increase Diversity in Clinical Trials
CVS Health Banks on Trust to Increase Diversity in Clinical Trials
BioSpace
CVS Health
clinical trials
clinical trial diversity
Flag link:
On Clinical Trials Day, CVS shares lessons learned from one year providing trial services
On Clinical Trials Day, CVS shares lessons learned from one year providing trial services
Pharmaforum
CVS Health
clinical trials
Flag link:

Pages